跳至主要内容
临床试验/NCT04220710
NCT04220710Unknown不适用

Methylation of cfDNA in Diagnosis and Differential Diagnosis of Ovarian Endometriosis

Peking Union Medical College Hospital1 个研究点 分布在 1 个国家目标入组 390 人开始时间: 2019年8月20日最近更新:
适应症

试验速览

阶段
不适用
入组人数
390
试验地点
1
主要终点
The efficacy of cfDNA methylation in the diagnosis of ovarian endometriosis

研究概览

简要总结

Methylation detection of circulating free DNA to identify markers for diagnosis and differential diagnosis of ovarian endometriosis.

详细描述

Methylation detection of circulating free DNA and FFPF samples from patients with ovarian endometriosis, ovarian cancer and other benign ovarian cysts will be performed to select markers for ovarian endometriosis diagnosis. The markers will be validated in patients with ovarian cysts found by ultrasound. The diagnosis accuracy of the markers will be evaluated by comparing with the pathological diagnosis.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • pathologically diagnosed as ovarian endometriosis;
  • surgery was performed in PUMCH

排除标准

  • a. combined with other gynecological benign and malignant tumors; b. clinically suspected malignant tumors; c. combined with other systemic malignancies or malignancies history; d. pregnant patients
  • patients with ovarian cancer:
  • Inclusion Criteria:
  • pathologically diagnosed as epithelial ovarian cancer;
  • surgery was performed in PUMCH
  • Exclusion Criteria:
  • combined with gynecological benign tumors and other malignant tumors;
  • combined with other systemic malignancies or malignancies history;
  • pregnant patients (3) patients with other benign ovarian tumors:
  • Inclusion Criteria:
  • pathologically diagnosed as benign ovarian tumors but not ovarian endometriosis;
  • surgery was performed in PUMCH
  • Exclusion Criteria:
  • a. combined with other gynecological benign and malignant tumors; b. clinically suspected malignant tumors; c. combined with other systemic malignancies or malignancies history; d. pregnant patients
  • Marker validation group:
  • Inclusion Criteria:
  • ovarian cysts found through ultrasound ;
  • surgery will be performed in PUMCH
  • Exclusion Criteria:
  • combined with other gynecological benign and malignant tumors;
  • clinically suspected malignant tumors;
  • combined with other systemic malignancies or malignancies history;
  • pregnant patients

结局指标

主要结局

The efficacy of cfDNA methylation in the diagnosis of ovarian endometriosis

时间窗: 12 months

The sensitivity, specificity and accuracy are calculated according to standard definitions to evaluate the efficacy of cfDNA methylation in the diagnosis of ovarian endometriosis

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

shuwang

Associate Professor

Peking Union Medical College Hospital

研究点 (1)

Loading locations...

相似试验